583 results on '"Ramnath, Nithya"'
Search Results
52. Data from Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer
53. The Lung Microbiome in Carcinogenesis and Immunotherapy Treatment
54. Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy
55. Porous PDMS‐Based Microsystem (ExoSponge) for Rapid Cost‐Effective Tumor Extracellular Vesicle Isolation and Mass Spectrometry‐Based Metabolic Biomarker Screening
56. Preoperative dose-dense docetaxel and cyclophosphamide alternating with epirubicin and cisplatin(ddDCEP): an effective, novel way of incorporating platinum in the treatment of early TNBC
57. Total neoadjuvant therapy (TNT) using 5FU and oxaliplatin followed by higher dose concurrent 5FU in locally advanced high-risk rectal adenocarcinoma including signet ring and mucinous cancers resulting in good complete response rates
58. Adoption of Extended-Interval Dosing of Single-Agent Pembrolizumab and Comparative Effectiveness vs Standard Dosing in Time-to-Treatment Discontinuation
59. KRAS-G12C Mutation Is Associated with Poor Outcome in Surgically Resected Lung Adenocarcinoma
60. Effects of Cigarette Smoking on Metabolism and Effectiveness of Systemic Therapy for Lung Cancer
61. Epigenetic Regulation of Vitamin D Metabolism in Human Lung Adenocarcinoma
62. Phase II Study of Perioperative Chemotherapy with Cisplatin and Pemetrexed in Non–Small-Cell Lung Cancer
63. Neoadjuvant Versus Adjuvant Systemic Therapy for Early-Stage Non-Small Cell Lung Cancer: The Changing Landscape Due to Immunotherapy.
64. Matrix Metalloproteinases in Gastric Cancer
65. Case report: A persistently expanded T cell response in an exceptional responder to radiation and atezolizumab for metastatic non-small cell lung cancer
66. Patterns of use and outcomes of peripherally inserted central catheters in hospitalized patients with solid tumors: A multicenter study
67. De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer
68. Patterns of use and outcomes of peripherally inserted central catheters in hospitalized patients with solid tumors: A multicenter study
69. Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer: A Phase 2 Clinical Trial
70. Expanded Circulating Tumor Cells from a Patient with ALK-Positive Lung Cancer Present with EML4-ALK Rearrangement Along with Resistance Mutation and Enable Drug Sensitivity Testing: A Case Study
71. Changes in Global Function and Regional Ventilation and Perfusion on SPECT During the Course of Radiotherapy in Patients With Non-Small-Cell Lung Cancer
72. Integrating Medical Genetics Into Precision Oncology Practice in the Veterans Health Administration: The Time Is Now
73. Molecular biomarkers and liquid biopsies in lung cancer
74. A phase I/II multisite study of rucaparib and pembrolizumab maintenance therapy in stage IV non-squamous non–small cell lung cancer after initial therapy with carboplatin, pemetrexed, and pembrolizumab.
75. Antiangiogenic Therapy for Lung Cancer: Small-Molecule Inhibitors
76. Adopting Weight-Based Dosing With Pharmacy-Level Stewardship Strategies Could Reduce Cancer Drug Spending By Millions
77. Development and Validation of a Quantitative Real-Time Polymerase Chain Reaction Classifier for Lung Cancer Prognosis
78. Immune Checkpoint Inhibitors and Risk of Type 1 Diabetes
79. Phase II Trial of Imatinib Maintenance Therapy After Irinotecan and Cisplatin in Patients With c-Kit–Positive, Extensive-Stage Small-Cell Lung Cancer
80. Substantial Variation in Peripherally Inserted Central Catheter Use and Outcomes in Patients with Hematologic Malignancies: A Multi-Center Study
81. Epidermal Growth Factor Receptor Mutations Carried in Extracellular Vesicle-Derived Cargo Mirror Disease Status in Metastatic Non-small Cell Lung Cancer
82. Assessment of patient satisfaction, financial, and environmental impacts of teleoncology.
83. Treatment Outcomes of Different Prognostic Groups of Patients on Cancer and Leukemia Group B Trial 39801: Induction Chemotherapy Followed by Chemoradiotherapy Compared with Chemoradiotherapy Alone for Unresectable Stage III Non-small Cell Lung Cancer
84. Apoptosis-Related (Survivin, Bcl-2), Tumor Suppressor Gene (p53), Proliferation (Ki-67), and Non-Receptor Tyrosine Kinase (Src) Markers Expression and Correlation With Clinicopathologic Variables in 60 Thymic Neoplasms
85. KRAS-G12C Mutation is Associated with Poor Outcome in Surgically Resected Lung Adenocarcinoma
86. Metachronous and synchronous presentation of acute myeloid leukemia and lung cancer
87. Thoracoscopic Organ Suffusion for Regional Lung Chemotherapy (Preliminary Results)
88. Treatment of Stage III Non-small Cell Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
89. Teleoncology for Veterans: High Patient Satisfaction Coupled With Positive Financial and Environmental Impacts
90. Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non–Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
91. It’s not ‘just a tube of blood’: principles of protocol development, sample collection, staffing and budget considerations for blood-based biomarkers in immunotherapy studies
92. In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors
93. Isolation of Circulating Biomarkers for Liquid Biopsy using Immunoaffinity‐Based Stimuli‐Responsive Hybrid Hydrogel Beads
94. Doubling of median overall survival in a nationwide cohort of veterans with stage III non-small cell lung cancer in the durvalumab era.
95. Should PICCs be avoided in patients with certain solid organ cancers?
96. What did you think of the hematology/oncology rotation? A survey of internal medicine residents
97. Integrative clinical genomics of metastatic cancer
98. High superoxide dismutase and low glutathione peroxidase activities in red blood cells predict susceptibility of lung cancer patients to radiation pneumonitis
99. Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches
100. Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.